IP Library Granted Patent US 12,076,225
Granted Patent B2
US 12,076,225 · App. 16/826,347 · Granted Sep 3, 2024

Ureteral catheters, bladder catheters, systems, kits and methods for inducing negative pressure to increase renal function

Inventors: John R. Erbey, II (Milton, GA); Jacob L. Upperco (Atlanta, GA); David E. Orr (Piedmont, SC); Michael Alan Fisher (Lawrenceville, GA); Patrick William Strane (Atlanta, GA); Lance Michael Black (Pearland, TX)
Assignee: Roivios Limited
A61F2/04A61M1/74A61M1/80A61M25/0017A61M25/007A61M25/04A61M25/10A61M27/008A61F2002/048A61F2220/0008A61F2230/0091A61M1/84A61M2205/3303A61M2205/3334A61M2210/1085A61M2210/1089
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,076,225
App. No.
16/826,347
Granted
Sep 3, 2024
Kind
B2
Abstract

Ureteral or bladder catheters and systems are provided, including (a) a proximal portion; and (b) a distal portion, the distal portion including a retention portion including an outer periphery or protective surface area which prevents mucosal tissue from occluding one or more protected drainage holes, ports, or perforations disposed within the outer periphery or protective surface area upon application of negative pressure through the catheter.

Claims (78)

1. A ureteral catheter comprising (a) a proximal portion; and (b) a distal portion, the distal portion comprising a retention portion comprising an outer periphery or protective surface area and one or more protected drainage holes, ports or perforations disposed on a protected surface area or inner surface area of the retention portion, and wherein, upon application of negative pressure, mucosal tissue conforms or collapses onto the outer periphery or protective surface area of the retention portion of the catheter and is thereby prevented or inhibited from occluding the one or more of the protected drainage holes, ports or perforations disposed on the protected surface area or inner surface area of the retention portion.

2. The ureteral catheter according to claim 1 , wherein the retention portion comprises one or more helical coils, each coil having an outwardly facing side and an inwardly facing side, and wherein the outer periphery or protective surface area comprises the outwardly facing side(s) of the one or more helical coil(s), and the one or more protected drainage holes, ports or perforations are disposed on the inwardly facing side(s) of the one or more helical coil(s).

3. The ureteral catheter according to claim 1 , wherein the retention portion is configured into a funnel-shaped support having an outer surface and an inner surface, and wherein the outer periphery or protective surface area comprises the outer surface of the funnel-shaped support, and the one or more drainage holes, ports or perforations are disposed on the inner surface of the funnel-shaped support.

4. The ureteral catheter according to claim 1 , wherein the retention portion is configured to be extended into a deployed position in which a diameter of the retention portion is greater than a diameter of the drainage lumen portion.

5. The ureteral catheter according to claim 1 , wherein the distal portion further comprises a drainage tube.

6. The ureteral catheter according to claim 1 , wherein the retention portion further comprises a drainage tube.

7. The ureteral catheter according to claim 1 , wherein the outer periphery or protective surface area establishes an unobstructed fluid column between the kidney and the proximal portion.

8. A bladder catheter comprising (a) a proximal portion; and (b) a distal portion, the distal portion comprising a retention portion comprising an outer periphery or protective surface area which prevents mucosal tissue from occluding one or more protected drainage holes, ports, or perforations disposed within the outer periphery or protective surface area upon application of negative pressure through the catheter.

9. The bladder catheter according to claim 8 , wherein the one or more protected drainage holes, ports or perforations are disposed on a protected surface area or inner surface area of the retention portion, and wherein, upon application of negative pressure, the mucosal tissue conforms or collapses onto the outer periphery or protective surface area of the retention portion of the catheter and is thereby prevented or inhibited from occluding the one or more of the protected drainage holes, ports or perforations.

10. The bladder catheter according to claim 8 , wherein the retention portion comprises one or more helical coils, each coil having an outwardly facing side and an inwardly facing side, and wherein the outer periphery or protective surface area comprises the outwardly facing side(s) of the one or more helical coil(s), and the one or more protected drainage holes, ports or perforations are disposed on the inwardly facing side(s) of the one or more helical coil(s).

11. The bladder catheter according to claim 8 , wherein the retention portion is configured into a funnel-shaped support having an outer surface and an inner surface, and wherein the outer periphery or protective surface area comprises the outer surface of the funnel-shaped support, and the one or more drainage holes, ports or perforations are disposed on the inner surface of the funnel-shaped support.

12. The bladder catheter according to claim 8 , wherein the retention portion is configured to be extended into a deployed position in which a diameter of the retention portion is greater than a diameter of the drainage lumen portion.

13. The bladder catheter according to claim 8 , wherein the distal portion further comprises a drainage tube.

14. The bladder catheter according to claim 8 , wherein the retention portion further comprises a drainage tube.

15. The bladder catheter according to claim 8 , wherein the outer periphery or protective surface area establishes an unobstructed fluid column between the kidney and the proximal portion.

16. A system for inducing negative pressure in a portion of a urinary tract of a patient, the system comprising:

(a) at least one ureteral catheter, the at least one ureteral catheter comprising a distal portion for insertion within the patient's kidney and a proximal portion;

(b) a bladder catheter comprising a distal portion for insertion within the patient's bladder and a proximal portion for receiving negative pressure from a negative pressure source,

wherein the distal portion of the at least one ureteral catheter and/or the bladder catheter further comprises a retention portion comprising an outer periphery or protective surface area which prevents mucosal tissue from occluding one or more protected drainage holes, ports, or perforations disposed within the outer periphery or protective surface area upon application of negative pressure through the catheter; and

(c) a negative pressure source for application of negative pressure through both the bladder catheter and the ureteral catheter(s), which in turn causes fluid from the kidney to be drawn into the ureteral catheter(s), through both the ureteral catheter(s) and the bladder catheter, and then outside of the patient's body.

17. The system according to claim 16 , wherein the proximal portion of the at least one ureteral catheter(s) is in fluid communication with the distal portion of the bladder catheter.

18. The system according to claim 16 , wherein the distal portion of the at least one ureteral catheter(s) comprises a retention portion that comprises the one or more protected drainage holes, ports or perforations and is configured to establish the outer periphery or protective surface area that inhibits mucosal tissue from occluding the one or more protected drainage holes, ports or perforations upon the application of negative pressure from the negative pressure source.

19. The system according to claim 18 , wherein the one or more protected drainage holes, ports or perforations are disposed on a protected surface area or inner surface area of the retention portion, and wherein, upon application of negative pressure, the mucosal tissue conforms or collapses onto the outer periphery or protective surface area of the retention portion of the catheter and is thereby prevented or inhibited from occluding the one or more of the protected drainage holes, ports or perforations.

20. The system according to claim 19 , wherein the distal portion of the bladder catheter comprises a retention portion that comprises the one or more protected drainage holes, ports or perforations and is configured to establish the outer periphery or protective surface area that inhibits mucosal tissue from occluding the one or more protected drainage holes, ports or perforations upon the application of negative pressure from the negative pressure source.

21. The system according to claim 16 , wherein the one or more protected drainage holes, ports or perforations are disposed on a protected surface area or inner surface area of the retention portion, and wherein, upon application of negative pressure, the mucosal tissue conforms or collapses onto the outer periphery or protective surface area of the retention portion of the catheter and is thereby prevented or inhibited from occluding the one or more of the protected drainage holes, ports or perforations.

22. The system according to claim 16 , further comprising one or more physiological sensors associated with the patient, the physiological sensors being configured to provide information representative of at least one physical parameter to a controller.

23. The system according to claim 16 , wherein the negative pressure source comprises a pump external to the patient's body for application of negative pressure through both the bladder catheter and the ureteral catheter, which in turn causes fluid from the kidney to be drawn into the ureteral catheter, through both the ureteral catheter and the bladder catheter, and then outside of the patient's body.

24. The system according to claim 16 , wherein the negative pressure source comprises a vacuum source external to the patient's body for application and regulation of negative pressure through both the bladder catheter and the ureteral catheter, which in turn causes fluid from the kidney to be drawn into the ureteral catheter, through both the ureteral catheter and the bladder catheter, and then outside of the patient's body.

25. The system according to claim 24 , wherein the vacuum source is selected from the group consisting of a wall suction source, vacuum bottle, and manual vacuum source.

26. The system according to claim 24 , wherein the vacuum source is provided by a pressure differential.

27. The system according to claim 16 , wherein the negative pressure received from the negative pressure source is controlled manually, automatically, or combinations thereof.

28. The system according to claim 16 , wherein a controller is used to regulate negative pressure from the negative pressure source.

29. The system according to claim 16 , wherein the negative pressure source has an accuracy of about 10 mmHg or less.

30. The system according to claim 16 , wherein the negative pressure is provided within a range of about 0.1 mm Hg to about 150 mm Hg.

31. A system for inducing negative pressure in a portion of a urinary tract of a patient, the system comprising:

(a) at least one ureteral catheter, the at least one ureteral catheter comprising a distal portion for insertion within the patient's kidney and a proximal portion;

(b) a bladder catheter comprising a distal portion for insertion within the patient's bladder and a proximal portion for receiving a pressure differential, wherein the pressure differential causes fluid from the kidney to be drawn into the ureteral catheter(s), through both the ureteral catheter(s) and the bladder catheter, and then outside of the patient's body, the pressure differential being applied to increase, decrease and/or maintain fluid flow therethrough,

wherein the distal portion of the at least one ureteral catheter or the bladder catheter comprising a retention portion comprising an outer periphery or protective surface area which prevents mucosal tissue from occluding one or more protected drainage holes, ports, or perforations disposed within the outer periphery or protective surface area upon application of negative pressure through the catheter.

32. A method for inducing negative pressure in a portion of a urinary tract of a patient, the method comprising:

deploying a ureteral catheter into a ureter of a patient to maintain patency of fluid flow between a kidney and a bladder of the patient, the ureteral catheter comprising a distal portion for insertion within the patient's kidney and a proximal portion;

deploying a bladder catheter into the bladder of the patient, wherein the bladder catheter comprises a distal portion for insertion within the patient's bladder and a proximal portion for application of negative pressure, the proximal portion extending outside of the patient's body,

wherein the distal portion of the ureteral catheter and/or the bladder catheter further comprises a retention portion comprising an outer periphery or protective surface area which prevents mucosal tissue from occluding one or more protected drainage holes, ports, or perforations disposed within the outer periphery or protective surface area upon application of negative pressure through the catheter; and

applying negative pressure to the proximal end of the bladder catheter to induce negative pressure in a portion of the urinary tract of the patient to remove fluid from the patient.

33. The method according to claim 32 , wherein the ureteral catheter is deployed and remains in the patient's body for at least 24 hours.

34. The method according to claim 32 , wherein the ureteral catheter is deployed and remains in the patient's body for at least 30 days or longer.

35. The method according to claim 32 , wherein the bladder catheter is replaced more often that the ureteral catheter.

36. The method according to claim 32 , wherein multiple bladder catheters are placed and removed during the indwell time for a single set of ureteral catheters.

37. A system for inducing negative pressure in a portion of a urinary tract of a patient, the system comprising:

(a) at least one ureteral catheter, the at least one ureteral catheter comprising a distal portion for insertion within the patient's kidney and a proximal portion for receiving negative pressure from a negative pressure source, wherein the distal portion comprises a retention portion comprising an outer periphery or protective surface area and one or more protected drainage holes, ports or perforations disposed on a protected surface area or inner surface area of the retention portion, and wherein, upon application of negative pressure, mucosal tissue conforms or collapses onto the outer periphery or protective surface area of the retention portion of the catheter and is thereby prevented or inhibited from occluding the one or more of the protected drainage holes, ports or perforations disposed on the protected surface area or inner surface area of the retention portion; and

(b) a negative pressure source for application of negative pressure through the ureteral catheter(s), which in turn causes fluid from the kidney to be drawn into the ureteral catheter(s), through the ureteral catheter(s), and then outside of the patient's body.

38. The system according to claim 37 , further comprising one or more physiological sensors associated with the patient, the physiological sensors being configured to provide information representative of at least one physical parameter to a controller.

39. The system according to claim 37 , wherein the negative pressure source comprises a pump external to the patient's body for application of negative pressure through the ureteral catheter, which in turn causes fluid from the kidney to be drawn into the ureteral catheter, through the ureteral catheter, and then outside of the patient's body.

40. The system according to claim 37 , wherein the negative pressure source comprises a vacuum source external to the patient's body for application and regulation of negative pressure through the ureteral catheter, which in turn causes fluid from the kidney to be drawn into the ureteral catheter, through the ureteral catheter, and then outside of the patient's body.

41. The system according to claim 40 , wherein the vacuum source is selected from the group consisting of a wall suction source, vacuum bottle, and manual vacuum source.

42. The system according to claim 40 , wherein the vacuum source is provided by a pressure differential.

43. The system according to claim 37 , wherein the negative pressure received from the negative pressure source is controlled manually, automatically, or combinations thereof.

44. The system according to claim 37 , wherein a controller is used to regulate negative pressure from the negative pressure source.

45. The system according to claim 37 , wherein the negative pressure source has an accuracy of about 10 mmHg or less.

46. The system according to claim 37 , wherein the negative pressure is provided within a range of about 0.1 mm Hg to about 150 mm Hg.

47. A ureteral catheter, comprising:

(a) a proximal portion; and

(b) a distal portion, the distal portion comprising a retention portion, wherein the retention portion comprises a sidewall that conforms to the anatomical shape of the renal pelvis and comprising an interior comprising opening(s) which provide a passageway to direct fluid toward a drainage lumen of the catheter, and wherein, upon application of negative pressure, mucosal tissue conforms or collapses onto the sidewall of the retention portion of the catheter and is thereby prevented or inhibited from occluding the opening(s) disposed on the sidewall of the retention portion.

48. The ureteral catheter according to claim 47 , wherein the sidewall conforms generally to a cavity of the renal pelvis of the kidney.

49. The ureteral catheter according to claim 47 , wherein the sidewall conforms generally to a curvature of a cavity of the renal pelvis of the kidney.

50. The ureteral catheter according to claim 47 , wherein the retention portion is angled with respect to a central longitudinal axis of an adjacent portion of the drainage lumen.

51. The ureteral catheter according to claim 47 , wherein the retention portion comprises one or more coils, each coil having an outwardly facing side and an inwardly facing side, and wherein the sidewall comprises the outwardly facing side(s) of the one or more helical coil(s), and the opening(s) are disposed on the inwardly facing side(s) of the one or more helical coil(s).

52. The ureteral catheter according to claim 47 , wherein the retention portion is configured into a funnel-shaped structure having an outer surface and an inner surface, and wherein the sidewall comprises the outer surface of the funnel-shaped structure, and the opening(s) are disposed on the inner surface of the funnel-shaped structure.

53. The ureteral catheter according to claim 47 , wherein the retention portion is configured to be extended into a deployed position in which a diameter of the retention portion is greater than a diameter of the drainage lumen.

54. A system for inducing negative pressure in a portion of a urinary tract of a patient, the system comprising:

(a) at least one ureteral catheter comprising:

(i) a proximal portion; and

(ii) a distal portion, the distal portion comprising a retention portion, wherein the retention portion comprises a sidewall that conforms to the anatomical shape of the renal pelvis and comprising an interior comprising opening(s) which provide a passageway to direct fluid toward a drainage lumen of the catheter; and

(b) a negative pressure source for application of negative pressure through the ureteral catheter, wherein, upon application of negative pressure, mucosal tissue conforms or collapses onto the sidewall of the retention portion of the catheter and is thereby prevented or inhibited from occluding the opening(s) disposed on the sidewall of the retention portion.

55. The system according to claim 54 , wherein the negative pressure source comprises a pump.

56. The system according to claim 54 , further comprising one or more physiological sensors associated with the patient, the physiological sensors being configured to provide information representative of at least one physical parameter to a controller.

57. The system according to claim 54 , wherein a controller is used to regulate negative pressure from the negative pressure source.

58. The system according to claim 54 , wherein the negative pressure source has an accuracy of about 10 mmHg or less.

59. The system according to claim 54 , wherein the negative pressure is provided within a range of about 0.1 mm Hg to about 150 mm Hg.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY INTERNAL ADDRESS PREVIOUSLY RECORDED AT REEL: 057647 FRAME: 0601. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Feb 22, 2022
From: STRATACA SYSTEMS, LTD.
To: ROIVIOS LIMITED
Reel/Frame 059279/0434 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2021
From: STRATACA SYSTEMS LTD.
To: ROIVIOS LIMITED
Reel/Frame 057647/0601 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 4, 2021
From: ERBEY, JOHN R., II; UPPERCO, JACOB L.; ORR, DAVID E.; FISHER, MICHAEL ALAN; STRANE, PATRICK WILLIAM; BLACK, LANCE MICHAEL
To: STRATACA SYSTEMS LIMITED
Reel/Frame 054794/0031 →
Continuity (18)
Continuation 16662536 · Oct 24, 2019
Continuation 16205987 · Nov 30, 2018
Continuation In Part 15879770 · Jan 25, 2018
Continuation In Part 15687064 · Aug 25, 2017
Continuation In Part 15411884 · Jan 20, 2017
Continuation In Part 15214955 · Jul 20, 2016
Continuation In Part 15687083 · Aug 25, 2017
Continuation In Part 15411884 · Jan 20, 2017
Continuation In Part 15214955 · Jul 20, 2016
Continuation In Part 15745823
Provisional Application 62300025 · Feb 25, 2016
Provisional Application 62278721 · Jan 14, 2016
Provisional Application 62260966 · Nov 30, 2015
Provisional Application 62194585 · Jul 20, 2015
Provisional Application 62278271 · Jan 13, 2016
Provisional Application 62489789 · Apr 25, 2017
Provisional Application 62489831 · Apr 25, 2017
Related Publication 20200215304A1 · Jul 9, 2020
Cited By (3)
US 12,575,844 US 12,642,542 US 12,642,543